Jump to content

Bupropion: Difference between revisions

From Pharmacopedia
[checked revision][checked revision]
No edit summary
No edit summary
Line 16: Line 16:
| pregnancy          =  
| pregnancy          =  
| legal              =  
| legal              =  
| intro              = <vote slug="test-single" type="single" options="Yes | No | Maybe">Try the single?</vote>
| intro              = <vote slug="bup-rec" type="single" options="Yes; No; Maybe">
Would you recommend Bupropion?
</vote>


<vote slug="test-multi" type="multi" options="Dogs | Cats | Both | Neither">Multi check?</vote>
<vote slug="bup-side" type="multi" options="Dry mouth; Insomnia; Anxiety; Headache; None">
Which side effects did you experience?
</vote>
| pharmacokinetics  =  
| pharmacokinetics  =  
| pharmacodynamics  =  
| pharmacodynamics  =  

Revision as of 02:04, 18 May 2026

NDRI, Antidepressant, Stimulant
Bupropion
Wellbutrin
Would you recommend Bupropion?
2
Which side effects did you experience?
1

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Interactions

Pharmacogenomic + mechanism interactions5 edges
Pharmacokinetic mechanismSubstrate / metabolism relationships from primary literature
Enzyme:CYP2D6 inhibitor strong Primary 85 / 100
Strong CYP2D6 inhibitor at therapeutic doses; reduces morphine generation from codeine.
reversible competitive, effect resolves over ~5 inhibitor half-lives
Inferred from pharmacokinetic dataMaterialised by the inference engine; provenance shown per row
Codeine pk lowers via CYP2D6 Inferred 85 / 100
Bupropion inhibits CYP2D6 (inhibitor_strong, intensity 85); Codeine is a prodrug_activated_by of CYP2D6 (intensity 100). Derived: Codeine exposure lowered.
reversible competitive, effect resolves over ~5 inhibitor half-lives
Inferred via Enzyme:CYP2D6 (exposure lowered)
Desipramine pk raises via CYP2D6 Inferred 68 / 100
Bupropion inhibits CYP2D6 (inhibitor_strong, intensity 85); Desipramine is a substrate_major of CYP2D6 (intensity 80). Derived: Desipramine exposure raised.
reversible competitive, effect resolves over ~5 inhibitor half-lives
Inferred via Enzyme:CYP2D6 (exposure raised)
Dextromethorphan pk raises via CYP2D6 Inferred 68 / 100
Bupropion inhibits CYP2D6 (inhibitor_strong, intensity 85); Dextromethorphan is a substrate_major of CYP2D6 (intensity 80). Derived: Dextromethorphan exposure raised.
reversible competitive, effect resolves over ~5 inhibitor half-lives
Inferred via Enzyme:CYP2D6 (exposure raised)
Nebivolol pk raises via CYP2D6 Inferred 68 / 100
Bupropion inhibits CYP2D6 (inhibitor_strong, intensity 85); Nebivolol is a substrate_major of CYP2D6 (intensity 80). Derived: Nebivolol exposure raised.
reversible competitive, effect resolves over ~5 inhibitor half-lives
Inferred via Enzyme:CYP2D6 (exposure raised)

Patient experience

Fluoxetine via Category:Antidepressants👤 exp n/a/5 outcome n/a (n=1)⚕️ exp 1.0/5 outcome +33.0 (n=1)

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
NDRI, Antidepressant, Stimulant
Common uses
Pharmacy
Pharmacology
Purported mechanism
Norepinephrine–dopamine reuptake inhibitor